GlassScriptPhysician profile
Frank Palella
NPI 1952329021
$986,699.22
in general payments reported to CMS, 2019-2025
8 companies · $141K in 2025
The $141K reported for 2025 was more than what 99% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187K · 2020: $103K · 2021: $105K · 2022: $162K · 2023: $129K · 2024: $158K · 2025: $141K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $340K · Consulting Fee: $47K · Travel and Lodging: $31K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $339,747.50 |
| Consulting Fee | $47,350.83 |
| Travel and Lodging | $30,717.84 |
| Food and Beverage | $11,136.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $435,476.35 | 2019-2025 | Cabenuva, Dovato, Apretude |
| Gilead Sciences, INC. | $334,712.99 | 2019-2025 | Biktarvy, Descovy, Yeztugo |
| Janssen Products, LP | $154,423.90 | 2019-2023 | Symtuza |
| Emd Serono, INC. | $39,863.90 | 2022-2025 | Serostim, Serostim |
| Merck Sharp & Dohme LLC | $15,530.05 | 2019-2025 | Pifeltro |
| Theratechnologies INC. | $6,535.08 | 2019-2021 | |
| Janssen Biotech, INC. | $90.39 | 2019-2022 | |
| Janssen Scientific Affairs, LLC | $66.56 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Palella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.